

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.01064792 |
| 2 | negative regulation of cell killing (GO:0031342) | 3.90855447 |
| 3 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.90855447 |
| 4 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.84487538 |
| 5 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.84487538 |
| 6 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.84487538 |
| 7 | modulation by symbiont of host immune response (GO:0052553) | 3.84487538 |
| 8 | positive regulation by symbiont of host defense response (GO:0052509) | 3.84487538 |
| 9 | modulation by symbiont of host defense response (GO:0052031) | 3.84487538 |
| 10 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.81236533 |
| 11 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.74804840 |
| 12 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.69721190 |
| 13 | macrophage activation involved in immune response (GO:0002281) | 3.49887850 |
| 14 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.38151351 |
| 15 | regulation of gamma-delta T cell activation (GO:0046643) | 3.36904073 |
| 16 | response to peptidoglycan (GO:0032494) | 3.36588961 |
| 17 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.30250260 |
| 18 | immunoglobulin mediated immune response (GO:0016064) | 3.28420119 |
| 19 | response to muramyl dipeptide (GO:0032495) | 3.27313151 |
| 20 | detection of other organism (GO:0098543) | 3.23615599 |
| 21 | negative regulation of interleukin-12 production (GO:0032695) | 3.17635210 |
| 22 | germinal center formation (GO:0002467) | 3.12190280 |
| 23 | detection of bacterium (GO:0016045) | 3.05216155 |
| 24 | stress fiber assembly (GO:0043149) | 3.00212178 |
| 25 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.99894554 |
| 26 | neutrophil activation involved in immune response (GO:0002283) | 2.99408566 |
| 27 | regulation of necroptotic process (GO:0060544) | 2.95340703 |
| 28 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.91164222 |
| 29 | protein localization to endosome (GO:0036010) | 2.86874399 |
| 30 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.83830384 |
| 31 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.81113241 |
| 32 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.80134232 |
| 33 | detection of external biotic stimulus (GO:0098581) | 2.77853324 |
| 34 | pinocytosis (GO:0006907) | 2.77200008 |
| 35 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.76932512 |
| 36 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.76442672 |
| 37 | detection of molecule of bacterial origin (GO:0032490) | 2.75959933 |
| 38 | amyloid precursor protein catabolic process (GO:0042987) | 2.74460980 |
| 39 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.73537478 |
| 40 | barbed-end actin filament capping (GO:0051016) | 2.71953902 |
| 41 | response to host immune response (GO:0052572) | 2.71653586 |
| 42 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.71653586 |
| 43 | cellular response to exogenous dsRNA (GO:0071360) | 2.70639230 |
| 44 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.64620298 |
| 45 | positive regulation of leukocyte degranulation (GO:0043302) | 2.63639434 |
| 46 | regulation of leukocyte degranulation (GO:0043300) | 2.61899030 |
| 47 | B cell receptor signaling pathway (GO:0050853) | 2.60817631 |
| 48 | regulation of antigen processing and presentation (GO:0002577) | 2.58539907 |
| 49 | response to host (GO:0075136) | 2.58190042 |
| 50 | response to host defenses (GO:0052200) | 2.58190042 |
| 51 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.58190042 |
| 52 | type I interferon signaling pathway (GO:0060337) | 2.58062220 |
| 53 | cellular response to type I interferon (GO:0071357) | 2.58062220 |
| 54 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.57202886 |
| 55 | negative regulation of necroptotic process (GO:0060546) | 2.57119939 |
| 56 | positive regulation of antigen processing and presentation (GO:0002579) | 2.56701020 |
| 57 | negative regulation of T cell mediated immunity (GO:0002710) | 2.55841686 |
| 58 | response to type I interferon (GO:0034340) | 2.55098549 |
| 59 | mannose metabolic process (GO:0006013) | 2.53646299 |
| 60 | T-helper 1 type immune response (GO:0042088) | 2.53564236 |
| 61 | regulation of mast cell degranulation (GO:0043304) | 2.53520388 |
| 62 | glycosphingolipid catabolic process (GO:0046479) | 2.52415126 |
| 63 | negative regulation of interleukin-6 production (GO:0032715) | 2.51267554 |
| 64 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.49910350 |
| 65 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.49832632 |
| 66 | NIK/NF-kappaB signaling (GO:0038061) | 2.48281517 |
| 67 | positive regulation of mast cell activation (GO:0033005) | 2.46338506 |
| 68 | response to laminar fluid shear stress (GO:0034616) | 2.46063296 |
| 69 | regulation of hypersensitivity (GO:0002883) | 2.46031265 |
| 70 | cellular extravasation (GO:0045123) | 2.45483436 |
| 71 | positive regulation of interferon-alpha production (GO:0032727) | 2.44913129 |
| 72 | macrophage activation (GO:0042116) | 2.44428406 |
| 73 | myeloid cell activation involved in immune response (GO:0002275) | 2.42201543 |
| 74 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.42161073 |
| 75 | detection of biotic stimulus (GO:0009595) | 2.41967416 |
| 76 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.41636313 |
| 77 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.39644499 |
| 78 | regulation of interferon-alpha production (GO:0032647) | 2.37445895 |
| 79 | microglial cell activation (GO:0001774) | 2.37322966 |
| 80 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.35876050 |
| 81 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.32201758 |
| 82 | positive regulation of mast cell degranulation (GO:0043306) | 2.32201758 |
| 83 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.31741613 |
| 84 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.29883387 |
| 85 | regulation of defense response to virus by virus (GO:0050690) | 2.29706738 |
| 86 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.29414836 |
| 87 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.28417933 |
| 88 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.27344601 |
| 89 | B cell homeostasis (GO:0001782) | 2.26365500 |
| 90 | positive regulation of B cell differentiation (GO:0045579) | 2.24577070 |
| 91 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.24556189 |
| 92 | regulation of mast cell activation (GO:0033003) | 2.21619980 |
| 93 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.20510131 |
| 94 | positive thymic T cell selection (GO:0045059) | 2.20395105 |
| 95 | T cell selection (GO:0045058) | 2.19725439 |
| 96 | positive regulation of tumor necrosis factor production (GO:0032760) | 2.18795599 |
| 97 | positive regulation of Rap GTPase activity (GO:0032854) | 2.18760514 |
| 98 | glycolipid catabolic process (GO:0019377) | 2.18426359 |
| 99 | negative regulation of innate immune response (GO:0045824) | 2.17400243 |
| 100 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.17275829 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.56621276 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.05118943 |
| 3 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.85143956 |
| 4 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.79943981 |
| 5 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.72283140 |
| 6 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.67639568 |
| 7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.63883544 |
| 8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.58934786 |
| 9 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.58199019 |
| 10 | MYC_22102868_ChIP-Seq_BL_Human | 2.36828769 |
| 11 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.32820087 |
| 12 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.32170934 |
| 13 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.26740726 |
| 14 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.23496201 |
| 15 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.22952644 |
| 16 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.19924597 |
| 17 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.18330871 |
| 18 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.14399602 |
| 19 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.09244008 |
| 20 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.06843548 |
| 21 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.05137835 |
| 22 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.03028650 |
| 23 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.01297667 |
| 24 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.97005320 |
| 25 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.90508390 |
| 26 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.89101185 |
| 27 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.87513087 |
| 28 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.84965941 |
| 29 | MAF_26560356_Chip-Seq_TH1_Human | 1.82946795 |
| 30 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.80178028 |
| 31 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.79908078 |
| 32 | SPI1_23127762_ChIP-Seq_K562_Human | 1.79831327 |
| 33 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.78048138 |
| 34 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.77389336 |
| 35 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.76888068 |
| 36 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.75699530 |
| 37 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.73472886 |
| 38 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.68604287 |
| 39 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.65182285 |
| 40 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.63899752 |
| 41 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.63323765 |
| 42 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.57980272 |
| 43 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.57226906 |
| 44 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.53439102 |
| 45 | UTX_26944678_Chip-Seq_JUKART_Human | 1.51548897 |
| 46 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.50097594 |
| 47 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.50024071 |
| 48 | * MYB_26560356_Chip-Seq_TH2_Human | 1.48334981 |
| 49 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.40698962 |
| 50 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.37786181 |
| 51 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.37236284 |
| 52 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.37108270 |
| 53 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.36700404 |
| 54 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.36508468 |
| 55 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.34385696 |
| 56 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30879643 |
| 57 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.28998678 |
| 58 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.27935772 |
| 59 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.27935772 |
| 60 | * MYB_26560356_Chip-Seq_TH1_Human | 1.27528359 |
| 61 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.26658555 |
| 62 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.26011274 |
| 63 | MAF_26560356_Chip-Seq_TH2_Human | 1.24382659 |
| 64 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.22606107 |
| 65 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.21694140 |
| 66 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.20851041 |
| 67 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.20740799 |
| 68 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19268398 |
| 69 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.16926051 |
| 70 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.16916267 |
| 71 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.15657039 |
| 72 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.13886677 |
| 73 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.10959968 |
| 74 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.10814459 |
| 75 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.06906741 |
| 76 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.06846874 |
| 77 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.06487870 |
| 78 | KDM2B_26808549_Chip-Seq_K562_Human | 1.05791271 |
| 79 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02822226 |
| 80 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02065645 |
| 81 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.02047374 |
| 82 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.01918293 |
| 83 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.01694212 |
| 84 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.00791094 |
| 85 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.00133606 |
| 86 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.98617715 |
| 87 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.97841955 |
| 88 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.97618551 |
| 89 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.97618551 |
| 90 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.97581234 |
| 91 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.96138565 |
| 92 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.94888479 |
| 93 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94521582 |
| 94 | GATA1_22025678_ChIP-Seq_K562_Human | 0.94120001 |
| 95 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.93531412 |
| 96 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.92753158 |
| 97 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.92583922 |
| 98 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.92005455 |
| 99 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.91917167 |
| 100 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.91879534 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.38196366 |
| 2 | MP0003436_decreased_susceptibility_to | 2.98870474 |
| 3 | MP0005451_abnormal_body_composition | 2.88067538 |
| 4 | MP0003303_peritoneal_inflammation | 2.82776038 |
| 5 | MP0005058_abnormal_lysosome_morphology | 2.67464941 |
| 6 | MP0009840_abnormal_foam_cell | 2.53560532 |
| 7 | MP0000685_abnormal_immune_system | 2.46661196 |
| 8 | MP0003724_increased_susceptibility_to | 2.25981356 |
| 9 | MP0003300_gastrointestinal_ulcer | 2.25148820 |
| 10 | MP0003191_abnormal_cellular_cholesterol | 2.21574821 |
| 11 | MP0002419_abnormal_innate_immunity | 2.18739159 |
| 12 | MP0005000_abnormal_immune_tolerance | 2.16665349 |
| 13 | MP0001800_abnormal_humoral_immune | 2.14540793 |
| 14 | MP0009785_altered_susceptibility_to | 2.12726366 |
| 15 | MP0001790_abnormal_immune_system | 2.12265912 |
| 16 | MP0005387_immune_system_phenotype | 2.12265912 |
| 17 | MP0003183_abnormal_peptide_metabolism | 2.10342636 |
| 18 | MP0005025_abnormal_response_to | 2.09786920 |
| 19 | MP0005671_abnormal_response_to | 2.08564717 |
| 20 | MP0004510_myositis | 2.07279806 |
| 21 | MP0002148_abnormal_hypersensitivity_rea | 2.01703906 |
| 22 | MP0008260_abnormal_autophagy | 2.00919986 |
| 23 | MP0006082_CNS_inflammation | 1.99323292 |
| 24 | MP0003763_abnormal_thymus_physiology | 1.95884250 |
| 25 | MP0002452_abnormal_antigen_presenting | 1.94237559 |
| 26 | MP0003172_abnormal_lysosome_physiology | 1.92824745 |
| 27 | MP0002723_abnormal_immune_serum | 1.90769466 |
| 28 | MP0004233_abnormal_muscle_weight | 1.80245573 |
| 29 | MP0003828_pulmonary_edema | 1.80149512 |
| 30 | MP0002420_abnormal_adaptive_immunity | 1.73389665 |
| 31 | MP0004947_skin_inflammation | 1.72607130 |
| 32 | MP0001819_abnormal_immune_cell | 1.71630584 |
| 33 | MP0000604_amyloidosis | 1.67912447 |
| 34 | MP0003646_muscle_fatigue | 1.64759518 |
| 35 | MP0001533_abnormal_skeleton_physiology | 1.58703851 |
| 36 | MP0002998_abnormal_bone_remodeling | 1.54439565 |
| 37 | MP0002405_respiratory_system_inflammati | 1.52548636 |
| 38 | MP0010155_abnormal_intestine_physiology | 1.51363001 |
| 39 | MP0005409_darkened_coat_color | 1.51314807 |
| 40 | MP0005464_abnormal_platelet_physiology | 1.48377426 |
| 41 | MP0002254_reproductive_system_inflammat | 1.47424858 |
| 42 | MP0003329_amyloid_beta_deposits | 1.46610498 |
| 43 | MP0002332_abnormal_exercise_endurance | 1.41334934 |
| 44 | MP0004130_abnormal_muscle_cell | 1.40524165 |
| 45 | MP0003091_abnormal_cell_migration | 1.34148369 |
| 46 | MP0009278_abnormal_bone_marrow | 1.33948097 |
| 47 | MP0001845_abnormal_inflammatory_respons | 1.32184891 |
| 48 | MP0000716_abnormal_immune_system | 1.31102736 |
| 49 | MP0002166_altered_tumor_susceptibility | 1.29328064 |
| 50 | MP0000751_myopathy | 1.26326455 |
| 51 | MP0002398_abnormal_bone_marrow | 1.23038396 |
| 52 | MP0005310_abnormal_salivary_gland | 1.21005271 |
| 53 | MP0008469_abnormal_protein_level | 1.19732849 |
| 54 | MP0001851_eye_inflammation | 1.16691112 |
| 55 | MP0004036_abnormal_muscle_relaxation | 1.13570954 |
| 56 | MP0009764_decreased_sensitivity_to | 1.12412514 |
| 57 | MP0003705_abnormal_hypodermis_morpholog | 1.11670272 |
| 58 | MP0003075_altered_response_to | 1.10562018 |
| 59 | MP0004808_abnormal_hematopoietic_stem | 1.07622922 |
| 60 | MP0003656_abnormal_erythrocyte_physiolo | 1.07547674 |
| 61 | MP0002009_preneoplasia | 1.05703739 |
| 62 | MP0000858_altered_metastatic_potential | 1.05110203 |
| 63 | MP0000343_altered_response_to | 1.02237521 |
| 64 | MP0002429_abnormal_blood_cell | 1.00553366 |
| 65 | MP0000689_abnormal_spleen_morphology | 1.00147691 |
| 66 | MP0009115_abnormal_fat_cell | 0.99114940 |
| 67 | MP0005670_abnormal_white_adipose | 0.98988035 |
| 68 | MP0002877_abnormal_melanocyte_morpholog | 0.98439631 |
| 69 | MP0003566_abnormal_cell_adhesion | 0.95771850 |
| 70 | MP0000747_muscle_weakness | 0.94308098 |
| 71 | MP0003045_fibrosis | 0.93196094 |
| 72 | MP0000249_abnormal_blood_vessel | 0.93074919 |
| 73 | MP0009333_abnormal_splenocyte_physiolog | 0.91899030 |
| 74 | MP0003221_abnormal_cardiomyocyte_apopto | 0.91561220 |
| 75 | MP0005397_hematopoietic_system_phenotyp | 0.90326142 |
| 76 | MP0001545_abnormal_hematopoietic_system | 0.90326142 |
| 77 | MP0004484_altered_response_of | 0.90320088 |
| 78 | MP0001958_emphysema | 0.89346794 |
| 79 | MP0003950_abnormal_plasma_membrane | 0.89301013 |
| 80 | MP0003866_abnormal_defecation | 0.88436911 |
| 81 | MP0004087_abnormal_muscle_fiber | 0.88351982 |
| 82 | MP0002722_abnormal_immune_system | 0.88284231 |
| 83 | MP0000465_gastrointestinal_hemorrhage | 0.86558029 |
| 84 | MP0001853_heart_inflammation | 0.86492806 |
| 85 | MP0003453_abnormal_keratinocyte_physiol | 0.85615605 |
| 86 | MP0008874_decreased_physiological_sensi | 0.85449015 |
| 87 | MP0004883_abnormal_blood_vessel | 0.84930508 |
| 88 | MP0004084_abnormal_cardiac_muscle | 0.83932184 |
| 89 | MP0002269_muscular_atrophy | 0.83513755 |
| 90 | MP0000759_abnormal_skeletal_muscle | 0.83458989 |
| 91 | MP0002933_joint_inflammation | 0.81755564 |
| 92 | MP0005165_increased_susceptibility_to | 0.81317811 |
| 93 | MP0005375_adipose_tissue_phenotype | 0.80456975 |
| 94 | MP0005076_abnormal_cell_differentiation | 0.80086501 |
| 95 | MP0001542_abnormal_bone_strength | 0.79119693 |
| 96 | MP0001873_stomach_inflammation | 0.78335676 |
| 97 | MP0005666_abnormal_adipose_tissue | 0.77946812 |
| 98 | MP0005330_cardiomyopathy | 0.76021815 |
| 99 | MP0005167_abnormal_blood-brain_barrier | 0.75845693 |
| 100 | MP0006138_congestive_heart_failure | 0.75336941 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of glycolipid metabolism (HP:0010969) | 4.06869620 |
| 2 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.06869620 |
| 3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.06869620 |
| 4 | Recurrent abscess formation (HP:0002722) | 3.72619765 |
| 5 | Recurrent bacterial skin infections (HP:0005406) | 3.64432425 |
| 6 | Eczematoid dermatitis (HP:0000976) | 3.55939690 |
| 7 | Asymmetric septal hypertrophy (HP:0001670) | 3.34820220 |
| 8 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.28018063 |
| 9 | Abnormality of macrophages (HP:0004311) | 3.13377747 |
| 10 | Increased cerebral lipofuscin (HP:0011813) | 3.09288838 |
| 11 | Distal lower limb muscle weakness (HP:0009053) | 3.07371293 |
| 12 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.93573972 |
| 13 | Gingivitis (HP:0000230) | 2.74528825 |
| 14 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.71363633 |
| 15 | Recurrent cutaneous fungal infections (HP:0011370) | 2.71363633 |
| 16 | Amyloidosis (HP:0011034) | 2.69228913 |
| 17 | Distal lower limb amyotrophy (HP:0008944) | 2.68342673 |
| 18 | Stomatitis (HP:0010280) | 2.67560513 |
| 19 | Systemic lupus erythematosus (HP:0002725) | 2.65519230 |
| 20 | Recurrent fungal infections (HP:0002841) | 2.61862090 |
| 21 | Recurrent skin infections (HP:0001581) | 2.57715982 |
| 22 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.55278005 |
| 23 | Spontaneous hematomas (HP:0007420) | 2.54031281 |
| 24 | Colitis (HP:0002583) | 2.53892974 |
| 25 | Fatigue (HP:0012378) | 2.53120159 |
| 26 | Dysostosis multiplex (HP:0000943) | 2.51427617 |
| 27 | Ragged-red muscle fibers (HP:0003200) | 2.45916857 |
| 28 | Exercise-induced myalgia (HP:0003738) | 2.45576031 |
| 29 | Myositis (HP:0100614) | 2.43269102 |
| 30 | Gastrointestinal stroma tumor (HP:0100723) | 2.39211559 |
| 31 | Mediastinal lymphadenopathy (HP:0100721) | 2.34974959 |
| 32 | Loss of speech (HP:0002371) | 2.34464509 |
| 33 | Recurrent viral infections (HP:0004429) | 2.32948918 |
| 34 | Increased IgE level (HP:0003212) | 2.30926246 |
| 35 | Bundle branch block (HP:0011710) | 2.29947623 |
| 36 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.28104619 |
| 37 | Peritonitis (HP:0002586) | 2.17925900 |
| 38 | Chest pain (HP:0100749) | 2.17635399 |
| 39 | Cellulitis (HP:0100658) | 2.17341353 |
| 40 | Vasculitis (HP:0002633) | 2.17165892 |
| 41 | Pustule (HP:0200039) | 2.16606948 |
| 42 | Increased connective tissue (HP:0009025) | 2.15793616 |
| 43 | Urticaria (HP:0001025) | 2.15501559 |
| 44 | Hyporeflexia of lower limbs (HP:0002600) | 2.14165072 |
| 45 | Ventricular tachycardia (HP:0004756) | 2.14022472 |
| 46 | Orchitis (HP:0100796) | 2.13578342 |
| 47 | Inflammation of the large intestine (HP:0002037) | 2.12649709 |
| 48 | Type 1 muscle fiber predominance (HP:0003803) | 2.12011178 |
| 49 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.09950839 |
| 50 | Muscle fiber splitting (HP:0003555) | 2.08805558 |
| 51 | Gastrointestinal inflammation (HP:0004386) | 2.04640165 |
| 52 | Rhabdomyolysis (HP:0003201) | 2.03699094 |
| 53 | EMG: myopathic abnormalities (HP:0003458) | 2.03111685 |
| 54 | Interstitial pulmonary disease (HP:0006530) | 2.00986766 |
| 55 | Muscle fiber inclusion bodies (HP:0100299) | 1.97927181 |
| 56 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.97384206 |
| 57 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.97384206 |
| 58 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.97384206 |
| 59 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.96410696 |
| 60 | T lymphocytopenia (HP:0005403) | 1.95406439 |
| 61 | Sudden death (HP:0001699) | 1.93265043 |
| 62 | Nemaline bodies (HP:0003798) | 1.91976187 |
| 63 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.91703214 |
| 64 | Thin bony cortex (HP:0002753) | 1.91316420 |
| 65 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.91031853 |
| 66 | Mucopolysacchariduria (HP:0008155) | 1.91031853 |
| 67 | Vacuolated lymphocytes (HP:0001922) | 1.89378673 |
| 68 | Gastrointestinal infarctions (HP:0005244) | 1.88418998 |
| 69 | Autoimmune thrombocytopenia (HP:0001973) | 1.88328126 |
| 70 | Frequent falls (HP:0002359) | 1.87313394 |
| 71 | Neurofibrillary tangles (HP:0002185) | 1.86063923 |
| 72 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.85150107 |
| 73 | Upper motor neuron abnormality (HP:0002127) | 1.84999189 |
| 74 | Myoglobinuria (HP:0002913) | 1.82987036 |
| 75 | Difficulty running (HP:0009046) | 1.80941652 |
| 76 | Hypergammaglobulinemia (HP:0010702) | 1.80940512 |
| 77 | Cerebral inclusion bodies (HP:0100314) | 1.76923807 |
| 78 | Meningitis (HP:0001287) | 1.76541419 |
| 79 | Diminished motivation (HP:0000745) | 1.75895141 |
| 80 | Increased variability in muscle fiber diameter (HP:0003557) | 1.75238226 |
| 81 | Emphysema (HP:0002097) | 1.75055509 |
| 82 | Disinhibition (HP:0000734) | 1.74412949 |
| 83 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.74370521 |
| 84 | Malnutrition (HP:0004395) | 1.74320878 |
| 85 | Restrictive lung disease (HP:0002091) | 1.73882048 |
| 86 | Optic neuritis (HP:0100653) | 1.71801022 |
| 87 | Retrobulbar optic neuritis (HP:0100654) | 1.71801022 |
| 88 | Purpura (HP:0000979) | 1.70833032 |
| 89 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.70663621 |
| 90 | Leukocytosis (HP:0001974) | 1.69112275 |
| 91 | Apathy (HP:0000741) | 1.68726526 |
| 92 | Right ventricular cardiomyopathy (HP:0011663) | 1.68676077 |
| 93 | Myocardial infarction (HP:0001658) | 1.68589919 |
| 94 | Axonal loss (HP:0003447) | 1.68477458 |
| 95 | Hematochezia (HP:0002573) | 1.68086348 |
| 96 | Increased serum ferritin (HP:0003281) | 1.67594395 |
| 97 | Progressive muscle weakness (HP:0003323) | 1.67309460 |
| 98 | Pulmonary infiltrates (HP:0002113) | 1.66994971 |
| 99 | Abnormality of the peritoneum (HP:0002585) | 1.66390970 |
| 100 | Abnormality of T cell number (HP:0011839) | 1.66364689 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 2.72297394 |
| 2 | PRPF4B | 2.70635956 |
| 3 | MAP3K14 | 2.53381482 |
| 4 | TRIB3 | 2.50978685 |
| 5 | RIPK4 | 2.50488112 |
| 6 | TTN | 2.35112309 |
| 7 | MAP4K1 | 2.30430737 |
| 8 | TYK2 | 2.21068567 |
| 9 | MAP3K13 | 2.03927144 |
| 10 | MAP2K3 | 2.03289973 |
| 11 | CSF1R | 1.98074236 |
| 12 | RIPK1 | 1.94469139 |
| 13 | TBK1 | 1.79716591 |
| 14 | EPHB1 | 1.77990420 |
| 15 | CDK12 | 1.71339653 |
| 16 | IRAK4 | 1.61449651 |
| 17 | ICK | 1.61023541 |
| 18 | BLK | 1.56429716 |
| 19 | NEK9 | 1.52247930 |
| 20 | ZAP70 | 1.50661322 |
| 21 | IKBKE | 1.41061205 |
| 22 | CSK | 1.40803564 |
| 23 | TAOK1 | 1.39604403 |
| 24 | KIT | 1.38891720 |
| 25 | JAK1 | 1.33440276 |
| 26 | JAK3 | 1.32295192 |
| 27 | MAP3K1 | 1.31706228 |
| 28 | MAP3K3 | 1.29604784 |
| 29 | MAPK7 | 1.27799155 |
| 30 | KSR2 | 1.25895715 |
| 31 | PRKD2 | 1.25403503 |
| 32 | MAP3K11 | 1.24041698 |
| 33 | CDC42BPA | 1.23307261 |
| 34 | SIK1 | 1.22315873 |
| 35 | IRAK3 | 1.16575928 |
| 36 | BRD4 | 1.10601784 |
| 37 | FES | 1.10417139 |
| 38 | IKBKB | 1.10066711 |
| 39 | OBSCN | 1.08810159 |
| 40 | MARK2 | 1.06674831 |
| 41 | CAMK1D | 1.03049905 |
| 42 | CAMK1G | 1.02565268 |
| 43 | FGR | 0.99702963 |
| 44 | TAOK2 | 0.98712191 |
| 45 | BTK | 0.98152705 |
| 46 | FGFR4 | 0.96418787 |
| 47 | SYK | 0.96357187 |
| 48 | MATK | 0.95164866 |
| 49 | TGFBR2 | 0.94164437 |
| 50 | SMG1 | 0.92661076 |
| 51 | HCK | 0.90908344 |
| 52 | MAP3K6 | 0.89532081 |
| 53 | SGK3 | 0.89222467 |
| 54 | PKN2 | 0.83953489 |
| 55 | MAPK12 | 0.83664228 |
| 56 | GRK7 | 0.83196980 |
| 57 | MOS | 0.79784889 |
| 58 | GRK6 | 0.78764911 |
| 59 | MYLK | 0.77417100 |
| 60 | JAK2 | 0.76142709 |
| 61 | PTK6 | 0.76076598 |
| 62 | TNK2 | 0.74886461 |
| 63 | CHUK | 0.74094014 |
| 64 | RPS6KA2 | 0.73688031 |
| 65 | PDGFRB | 0.73644961 |
| 66 | LYN | 0.73588629 |
| 67 | RPS6KC1 | 0.70190441 |
| 68 | RPS6KL1 | 0.70190441 |
| 69 | PDK1 | 0.69879356 |
| 70 | BMPR2 | 0.69685787 |
| 71 | PDPK1 | 0.69034637 |
| 72 | MAPK11 | 0.68702454 |
| 73 | HIPK2 | 0.68397178 |
| 74 | MAP3K5 | 0.66934433 |
| 75 | MAP3K7 | 0.65968541 |
| 76 | PDGFRA | 0.65745607 |
| 77 | SIK3 | 0.65534377 |
| 78 | LCK | 0.63065995 |
| 79 | TRPM7 | 0.60279887 |
| 80 | STK38 | 0.60042667 |
| 81 | DYRK1B | 0.59936798 |
| 82 | MAP2K2 | 0.59513102 |
| 83 | IRAK1 | 0.59376964 |
| 84 | MAP3K2 | 0.58554270 |
| 85 | ITK | 0.58321198 |
| 86 | STK10 | 0.57735991 |
| 87 | PTK2B | 0.57604197 |
| 88 | ARAF | 0.57298094 |
| 89 | CAMK4 | 0.57124302 |
| 90 | RPS6KA6 | 0.56340771 |
| 91 | CDK6 | 0.53981994 |
| 92 | PRKAA2 | 0.51614162 |
| 93 | PRKD1 | 0.51551893 |
| 94 | MTOR | 0.48801674 |
| 95 | RET | 0.47077802 |
| 96 | TEC | 0.46222271 |
| 97 | CAMKK1 | 0.45590199 |
| 98 | FLT3 | 0.45512443 |
| 99 | DDR2 | 0.44604439 |
| 100 | MAP2K1 | 0.44037238 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 2.34383354 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.26872494 |
| 3 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.21078226 |
| 4 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.10461097 |
| 5 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.99916141 |
| 6 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.99787256 |
| 7 | Asthma_Homo sapiens_hsa05310 | 1.93253875 |
| 8 | Allograft rejection_Homo sapiens_hsa05330 | 1.91499281 |
| 9 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.82011483 |
| 10 | Viral myocarditis_Homo sapiens_hsa05416 | 1.79471454 |
| 11 | Tuberculosis_Homo sapiens_hsa05152 | 1.72496563 |
| 12 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.72459563 |
| 13 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.69619933 |
| 14 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.68216137 |
| 15 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.63373825 |
| 16 | Lysosome_Homo sapiens_hsa04142 | 1.57619578 |
| 17 | Influenza A_Homo sapiens_hsa05164 | 1.55094445 |
| 18 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.53300305 |
| 19 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.45379321 |
| 20 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.43963108 |
| 21 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.41227241 |
| 22 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.40470113 |
| 23 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.38200165 |
| 24 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.36244747 |
| 25 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.36233824 |
| 26 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.35698400 |
| 27 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.35695938 |
| 28 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.29543820 |
| 29 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.28512163 |
| 30 | Measles_Homo sapiens_hsa05162 | 1.22936839 |
| 31 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.21202080 |
| 32 | Hepatitis C_Homo sapiens_hsa05160 | 1.21036171 |
| 33 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.15503951 |
| 34 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.14967639 |
| 35 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.14934671 |
| 36 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.12673313 |
| 37 | Pertussis_Homo sapiens_hsa05133 | 1.11538384 |
| 38 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.10693134 |
| 39 | Phagosome_Homo sapiens_hsa04145 | 1.09982899 |
| 40 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.08950982 |
| 41 | Hepatitis B_Homo sapiens_hsa05161 | 1.08709258 |
| 42 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.08582879 |
| 43 | Malaria_Homo sapiens_hsa05144 | 1.07911269 |
| 44 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.07308242 |
| 45 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.05296343 |
| 46 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.05109921 |
| 47 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.05021326 |
| 48 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.04016023 |
| 49 | Shigellosis_Homo sapiens_hsa05131 | 1.03937763 |
| 50 | Salmonella infection_Homo sapiens_hsa05132 | 1.03024769 |
| 51 | Legionellosis_Homo sapiens_hsa05134 | 1.02253532 |
| 52 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.01036144 |
| 53 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.99965943 |
| 54 | Platelet activation_Homo sapiens_hsa04611 | 0.98967078 |
| 55 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.96110883 |
| 56 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.96038769 |
| 57 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.96010896 |
| 58 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.94579720 |
| 59 | Apoptosis_Homo sapiens_hsa04210 | 0.93255398 |
| 60 | Insulin resistance_Homo sapiens_hsa04931 | 0.91971507 |
| 61 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.90454493 |
| 62 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.90334580 |
| 63 | Amoebiasis_Homo sapiens_hsa05146 | 0.84779586 |
| 64 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.78917727 |
| 65 | Bladder cancer_Homo sapiens_hsa05219 | 0.78561557 |
| 66 | Endometrial cancer_Homo sapiens_hsa05213 | 0.77181604 |
| 67 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.73910498 |
| 68 | Endocytosis_Homo sapiens_hsa04144 | 0.73879086 |
| 69 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.73393545 |
| 70 | Prion diseases_Homo sapiens_hsa05020 | 0.72984639 |
| 71 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.72555817 |
| 72 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.72065580 |
| 73 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.71808075 |
| 74 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.71097583 |
| 75 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.68692002 |
| 76 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.68077473 |
| 77 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.64922700 |
| 78 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.64113056 |
| 79 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.61037553 |
| 80 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.59989333 |
| 81 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.57140290 |
| 82 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.56269795 |
| 83 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.55219523 |
| 84 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.55215044 |
| 85 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.54610248 |
| 86 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.53416230 |
| 87 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.52569878 |
| 88 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.52391428 |
| 89 | Glioma_Homo sapiens_hsa05214 | 0.51484742 |
| 90 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.50574748 |
| 91 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.50357526 |
| 92 | Focal adhesion_Homo sapiens_hsa04510 | 0.49283143 |
| 93 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.49160668 |
| 94 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.48238223 |
| 95 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.48201469 |
| 96 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.47684081 |
| 97 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.47663952 |
| 98 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.47493523 |
| 99 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.47186740 |
| 100 | Prostate cancer_Homo sapiens_hsa05215 | 0.46910387 |

